Pharmacotherapy

This casebook is designed to help students develop the skills required to identify and resolve drug therapy problems through the use of patient case studies.

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.

Although "using both medications and psychotherapy in all patients may not necessarily be most cost-efficient or most effective," according to Beitman (psychiatry, U. of Missouri-Columbia) and his collaborators, it seems important to determine when monotreatment, combined therapy, or integrated treatment may be the best choice. They overview the issues involved in such therapies, and then focus in on research perspectives and understandings of psychodynamic neurobiology. Annotation (c)2003 Book News, Inc., Portland, OR (booknews.com).

BONE AND JOINT DISORDERS Edited by Terry L. Schwinghammer 1. Gout and Hyperuricemia 2. Osteoarthritis 3. Osteoporosis 4. Rheumatoid Arthritis CARDIOVASCULAR DISORDERS Edited by Terry L. Schwinghammer 5. Arrhythmias 6. Cardiopulmonary Resuscitation 7. Heart Failure 8. Hyperlipidemia 9.

This is a no-nonsense guide to drug treatment in the intensive care unit. It covers the most commonly encountered conditions and is organized by system. Management of each condition is tersely outlined step-by-step in table format. The book also includes non-drug information that is essential to making informed, evidence-based pharmacotherapy decisions, such as risk scores, scales, and assessment tools. The Second Edition has been revised to reflect the latest critical care practice guidelines and up-to-date drug and non-drug information.

Easy-to-follow disorder-based organization that surveys the full range of organ system disorders treated in pharmacy practice Knowledge-building boxed features within chapters, consisting of: Clinical Presentation & Diagnosis, Patient Encounters, and Patient Care and Monitoring Guidelines A standardized chapter format Laboratory values expressed in both conventional units and Systemé International (SI) units

This volume provides readers with the most updated scientific information on the efficacy and safety of medicines for children and adolescents. The book enriches the understanding of pediatric pharmacotherapy for health professionals, regulatory agencies, pharmaceutical companies and learned societies. It contains important information on the pharmacodynamics and pharmacokinetics of drugs. It summarizes the latest investigations on the effects of pharmacological treatments in relation to and dependent on age, gender, fat mass and disease status. Therefore and importantly, this volume reviews the latest data on how pharmacotherapy has to be adjusted and personalized in regards to stages of development and during the pediatric lifespan from neonate through adolescence. In addition, the topic of rare diseases and special challenges for pharmacotherapy will be included and will provide readers with the necessary knowledge to handle complex diseases and treatment strategies especially in relation to pharmacotherapy of rare and orphan diseases.